Aptahem AB (publ) (APTA.ST)

STO • Currency in SEK

kr 1.75

+kr 0.03

+1.45%

Last Update: 29 Aug 2025, 15:29

kr 30.21M

Market Cap

-1.03

P/E Ratio (TTM)

—

Forward Dividend Yield

kr 0.56 - kr 4.50

52 Week Range

APTA.ST Stock Price Chart

Explore Aptahem AB (publ) interactive price chart. Choose custom timeframes to analyze APTA.ST price movements and trends.

APTA.ST Company Profile

Discover essential business fundamentals and corporate details for Aptahem AB (publ) (APTA.ST) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

17 Apr 2015

Employees

4.00

Website

https://www.aptahem.com

CEO

Mikael Lindstam

Description

Aptahem AB (publ), a clinical stage biotechnology company, develops aptamer-based pharmaceuticals for the treatment of acute life-threatening conditions. Its principal pharmaceutical candidate is Apta-1, which is in preclinical stage to prevent mortality rate caused by organ and tissue damage in sepsis patients. The company has collaborations with various academic groups, including Consortium with Orebro University, Seattle Children's Research Institute, and University Health Network. Aptahem AB (publ) was incorporated in 2014 and is based in Malmö, Sweden.

APTA.ST Financial Timeline

Browse a chronological timeline of Aptahem AB (publ) corporate events including earnings releases, dividend announcements, and stock splits.

Stock split effective on 8 Jul 2024

Shares were split 1 : 100 , changing the number of shares outstanding and the price per share accordingly.

Stock split effective on 8 Jun 2023

Shares were split 253 : 250 , changing the number of shares outstanding and the price per share accordingly.

Stock split effective on 15 Nov 2022

Shares were split 1013 : 1000 , changing the number of shares outstanding and the price per share accordingly.

Stock split effective on 24 Aug 2021

Shares were split 1029 : 1000 , changing the number of shares outstanding and the price per share accordingly.

Stock split effective on 1 Oct 2020

Shares were split 22 : 21 , changing the number of shares outstanding and the price per share accordingly.

APTA.ST Stock Performance

Access detailed APTA.ST performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.